about
Either non-homologous ends joining or homologous recombination is required to repair double-strand breaks in the genome of macrophage-internalized Mycobacterium tuberculosisThe role of 3-ketosteroid 1(2)-dehydrogenase in the pathogenicity of Mycobacterium tuberculosis.Cholesterol oxidase is indispensable in the pathogenesis of Mycobacterium tuberculosisApplication of intracellular alkaline phosphatase activity measurement in detection of neutrophil adherence in vitro.The interaction of HspA1A with TLR2 and TLR4 in the response of neutrophils induced by ovarian cancer cells in vitro.Evaluation of nitric oxide donors impact on cisplatin resistance in various ovarian cancer cell lines.Mycobacterium tuberculosis RecA is indispensable for inhibition of the mitogen-activated protein kinase-dependent bactericidal activity of THP-1-derived macrophages in vitro.Cholesterol oxidase binds TLR2 and modulates functional responses of human macrophages.Nitric oxide donors reduce the invasion ability of ovarian cancer cells in vitro.Nitric oxide donors: spermine/NO and diethylenetriamine/NO induce ovarian cancer cell death and affect STAT3 and AKT signaling proteins.Seasonal changes in activities of human neutrophils in vitro.Oxidative and adhesive responses of human neutrophils to nitrovasodilators in vitro: the role of protein kinases.Modulation of human neutrophil activity by adenosine modified with a carborane pharmacophore.Flow cytometric evaluation of human neutrophil apoptosis during nitric oxide generation in vitro: the role of exogenous antioxidants.Influence of opioid peptides on human neutrophil apoptosis and activation in vitro.Nitric oxide generation from hydroxylamine in the presence of neutrophils and in the cell-free system.Effect of exogenous opioid peptides on TNF-alpha-induced human neutrophil apoptosis in vitro.Involvement of nitric oxide donor compounds in the bactericidal activity of human neutrophils in vitro.Role of the complement-lectin pathway in anaphylactoid reaction induced with lipopolysaccharide in mice.Effect of nitric oxide donors on NADPH oxidase signaling pathway in human neutrophils in vitro.Severe inhibition of lipooligosaccharide synthesis induces TLR2-dependent elimination of Mycobacterium marinum from THP1-derived macrophages.Ferulic acid but not alpha-lipoic acid effectively protects THP-1-derived macrophages from oxidant and pro-inflammatory response to LPS.Specific cellular and humoral reactions as markers of Listeria monocytogenes infections.Sub-optimal primary surgery leads to unfavorable immunological changes in ovarian cancer patients.Secretion of cytokines and heat shock protein (HspA1A) by ovarian cancer cells depending on the tumor type and stage of disease.Antitumoral Activity Of Nitric Oxide-Releasing Compounds.Ovarian cancer cells modulate human blood neutrophils response to activation in vitro.Analysis of preoperative blood platelet parameters in terms of diversity of epithelial ovarian cancer.Heterogeneity of the Mac-1 expression on peripheral blood neutrophils in patients with different types of epithelial ovarian cancer.[Weakness of cellular response to Listeria antigens in pregnant mice]Effects of gonadotrophin on resistance to Listeria monocytogenes infection in mice.JAK3, STAT3 and CD3-zeta signaling proteins status in regard to the lymphocytes function in patients with ovarian cancer.Cisplatin-induced ERK1/2 activity promotes G1 to S phase progression which leads to chemoresistance of ovarian cancer cells.The Potential Role of iNOS in Ovarian Cancer Progression and ChemoresistanceListeria monocytogenes infection in pregnant mice: abnormalities in the function of non-adherent accessory light density dendritic cellsThe production of nitric oxide and tumor necrosis factor by murine macrophages infected with mycobacterial strains differing by hemolytic activityListeria monocytogenes infection in mice treated with pentoxifyllineSignal transduction pathways affected by nitric oxide donors during neutrophil functional response in vitroProduction of cytokines during interaction of peripheral blood mononuclear cells with autologous ovarian cancer cells or benign ovarian tumour cellsNeutrophil--CD4+CD25+ T regulatory cell interactions: a possible new mechanism of infectious tolerance
P50
Q34411513-47C90E00-6CED-4EEF-8F98-34DA27E09B10Q34593313-EECD44C6-0229-4946-9E02-EAE68EC6109FQ34988959-6A265B94-5511-41C8-A2F8-C8F3A255C060Q35104233-26549A3D-8ED5-4506-84ED-3A8B4D94B4F0Q36309893-93C9D29B-3589-43B3-84E8-4A01C025277EQ38757512-A37F2E2D-007E-4E25-92CC-80F250942D4AQ38914450-5EE54B28-474E-4454-99FB-5E9DFC99625FQ38966377-E0F64DEF-E8AC-45E0-894A-33F8D0BBB28EQ38974442-CD95D6C2-486E-4E8C-8D08-379EAAEF1E9DQ39093404-95B5F0F8-610C-49BD-832B-D9F248DF49F9Q40086035-FADA5BA8-E96E-4D0E-BE7B-D7E932344634Q42202166-D751B4F4-5FFB-4B72-9D38-682366B9B010Q42215569-3F5F8A33-F4C8-4DC5-B3CF-B38EC968FAC1Q42463247-BA9CF8AA-AF78-4F0C-BC50-718328826B90Q42982751-E5435681-C2F8-4C05-80ED-EBD8776B63EBQ43734611-BC601E28-BD0D-45B5-97F8-BFE597AA0154Q44142449-BCEFD107-C59F-4CAC-8160-7D4F93024117Q44391245-B119D719-2041-4BE6-826D-F77DD01C1ADAQ44600221-13566F85-3EDA-4823-8E96-2507E181FBE9Q46106185-67C6E07C-4CDE-4DA6-82E0-DA44A1766CB6Q46252622-5910FED0-92B8-46CC-9D07-EB8988781157Q46312094-DC69FC45-91BC-410F-BD36-F59F86E7F301Q49239652-3A14C662-B06E-440F-BCBC-38E0E0D108B2Q50091014-3813257F-23F6-481A-9CD9-C5E9DF758384Q50881369-1D471A1E-65D2-4C5E-BD8E-5610053ED0C2Q51152199-ECECC2A6-63FD-4B2B-B12B-475568A7A087Q51697780-169112A0-829E-4EA9-AFB9-A12E1CBCC756Q51732590-F17887B1-2A88-450D-8A39-19878EADB73FQ53279284-DBA764DC-5E57-40EC-880C-E1C4A6EB6D48Q54253836-42A1571B-7EFE-424B-ACFA-52915A996BDEQ54307006-67D3EC48-CA79-44AB-9B58-5CDB22966A4BQ54538366-65253FE3-DCA2-4E25-89A4-7AD755AF10B5Q55122746-E68BC108-7767-483F-A3AC-6860EF181CB4Q64064052-7DAC0247-BFD6-4654-9D1A-2DB36E6FF1AFQ70972690-A4170CB2-C9DA-4E3C-83F1-76F79A68E6CFQ73101087-5FF9A770-572E-4F00-B5E2-EF0C615D4A49Q73326766-FBB729E3-02D8-4996-8AB7-4455850C6713Q80691112-63B4CB54-9CC6-4A9E-96D1-B0DBBCCEEBCAQ84043773-AA2F3C9C-A452-4D1E-A825-29C082B3A7B2Q84504702-6ABA4A3F-F057-47A2-9E84-995410F991C1
P50
description
Polish molecular biologist and immunologist
@en
Pools onderzoekster
@nl
polska biolog molekularna i immunolog
@pl
name
Magdalena Klink
@ast
Magdalena Klink
@ca
Magdalena Klink
@cs
Magdalena Klink
@en
Magdalena Klink
@es
Magdalena Klink
@ga
Magdalena Klink
@gl
Magdalena Klink
@hr
Magdalena Klink
@hsb
Magdalena Klink
@it
type
label
Magdalena Klink
@ast
Magdalena Klink
@ca
Magdalena Klink
@cs
Magdalena Klink
@en
Magdalena Klink
@es
Magdalena Klink
@ga
Magdalena Klink
@gl
Magdalena Klink
@hr
Magdalena Klink
@hsb
Magdalena Klink
@it
altLabel
Magdalena Teresa Klink
@pl
prefLabel
Magdalena Klink
@ast
Magdalena Klink
@ca
Magdalena Klink
@cs
Magdalena Klink
@en
Magdalena Klink
@es
Magdalena Klink
@ga
Magdalena Klink
@gl
Magdalena Klink
@hr
Magdalena Klink
@hsb
Magdalena Klink
@it
P106
P214
P1153
7003822126
P1412
P1559
Magdalena Klink
@pl
P21
P214
P27
P31
P3124
P496
0000-0002-9870-7391
P7859
lccn-n2014182355